| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 214-222, Copyright © 1994 by Endocrine Society
ARTICLES |
CC Mastick, H Kato, CT Roberts Jr, D LeRoith and AR Saltiel
Department of Signal Transduction, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co., Ann Arbor, Michigan 48105.
Signal transduction pathways stimulated by insulin or insulin-like growth factor-I (IGF-I) were compared in transfected NIH3T3 fibroblast cell lines expressing the human insulin receptor, IGF-I receptor, or a chimeric IGF-I receptor with its carboxy-terminal tail replaced with that of the insulin receptor (approximately 1 x 10(6) receptors/cell). Although receptor autophosphorylation was very similar in the three cell lines overexpressing receptors (EC50 = 1-3 nM), there were differences detected in the protein tyrosine phosphorylation stimulated by insulin and IGF-I in these cells. Although no substrates specific for the insulin receptor were detected, phosphorylation of a 170- kilodalton (kDa; IRS-1) and a 70-kDa protein was 10 times more sensitive to insulin than to IGF-I (EC50 = 1.5-2.5 vs. 14-23 nM). The chimeric receptor stimulated significantly lower levels of phosphorylation of several proteins relative to the wild-type IGF-I receptor. Activation of phosphatidylinositol 3'-kinase paralleled phosphorylation of the 170- and 70-kDa proteins. Despite these differences in protein tyrosine phosphorylation, stimulation of mitogen- activated protein (MAP) kinase and DNA synthesis were very similar in the three cell lines overexpressing receptors. Little difference was detected in Shc phosphorylation or MAP kinase activation through the three receptors, although activation of MAP kinase was more efficiently coupled to the platelet-derived growth factor receptor than to any of the overexpressed receptors. All three receptors stimulated DNA synthesis to levels comparable to 10% serum, with similar sensitivities (EC50 = 1.5-3.5 nM).
This article has been cited by other articles:
![]() |
C. Mulligan, J. Rochford, G. Denyer, R. Stephens, G. Yeo, T. Freeman, K. Siddle, and S. O'Rahilly Microarray Analysis of Insulin and Insulin-like Growth Factor-1 (IGF-1) Receptor Signaling Reveals the Selective Up-regulation of the Mitogen Heparin-binding EGF-like Growth Factor by IGF-1 J. Biol. Chem., November 1, 2002; 277(45): 42480 - 42487. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sasaoka, M. Ishiki, T. Wada, H. Hori, H. Hirai, T. Haruta, H. Ishihara, and M. Kobayashi Tyrosine Phosphorylation-Dependent and -Independent Role of Shc in the Regulation of IGF-1-Induced Mitogenesis and Glycogen Synthesis Endocrinology, December 1, 2001; 142(12): 5226 - 5235. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwamoto, S. Fukumoto, K. Kanaoka, E. Sakai, M. Shibata, E. Fukumoto, J.-i. Inokuchi, K. Takamiya, K. Furukawa, K. Furukawa, et al. Lactosylceramide Is Essential for the Osteoclastogenesis Mediated by Macrophage-Colony-stimulating Factor and Receptor Activator of Nuclear Factor-kappa B Ligand J. Biol. Chem., November 30, 2001; 276(49): 46031 - 46038. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Vella, L Sciacca, G Pandini, R Mineo, S Squatrito, R Vigneri, and A Belfiore The IGF system in thyroid cancer: new concepts Mol. Pathol., June 1, 2001; 54(3): 121 - 124. [Abstract] [Full Text] |
||||
![]() |
T. Nedachi, M. Akahori, M. Ariga, H. Sakamoto, N. Suzuki, K. Umesaki, F. Hakuno, and S.-I. Takahashi Tyrosine Kinase and Phosphatidylinositol 3-Kinase Activation Are Required for Cyclic Adenosine 3',5'-Monophosphate-Dependent Potentiation of Deoxyribonucleic Acid Synthesis Induced by Insulin-Like Growth Factor-I in FRTL-5 Cells Endocrinology, July 1, 2000; 141(7): 2429 - 2438. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Urso, D. L. Cope, H. E. Kalloo-Hosein, A. C. Hayward, J. P. Whitehead, S. O'Rahilly, and K. Siddle Differences in Signaling Properties of the Cytoplasmic Domains of the Insulin Receptor and Insulin-like Growth Factor Receptor in 3T3-L1 Adipocytes J. Biol. Chem., October 22, 1999; 274(43): 30864 - 30873. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mutoh, A. Tokuda, J.-i. Inokuchi, and M. Kuriyama Glucosylceramide Synthase Inhibitor Inhibits the Action of Nerve Growth Factor in PC12 Cells J. Biol. Chem., October 2, 1998; 273(40): 26001 - 26007. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Manes, E. Mira, M. d. M. Barbacid, A. Cipres, P. Fernandez-Resa, J. M. Buesa, I. Merida, M. Aracil, G. Marquez, and C. Martinez-A Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3 J. Biol. Chem., October 10, 1997; 272(41): 25706 - 25712. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Kalloo-Hosein, J. P. Whitehead, M. Soos, J. M. Tavare, K. Siddle, and S. O'Rahilly Differential Signaling to Glycogen Synthesis by the Intracellular Domain of the Insulin versus the Insulin-like Growth Factor-1 Receptor. EVIDENCE FROM STUDIES OF TrkC-CHIMERAS J. Biol. Chem., September 26, 1997; 272(39): 24325 - 24332. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Esposito, V. A. Blakesley, A. P. Koval, A. G. Scrimgeour, and D. LeRoith Tyrosine Residues in the C-Terminal Domain of the Insulin-Like Growth Factor-I Receptor Mediate Mitogenic and Tumorigenic Signals Endocrinology, July 1, 1997; 138(7): 2979 - 2988. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Scrimgeour, V. A. Blakesley, B. S. Stannard, and D. LeRoith Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Pathways Are Not Sufficient for Insulin-Like Growth Factor I-Induced Mitogenesis and Tumorigenesis Endocrinology, June 1, 1997; 138(6): 2552 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Burikhanov, K. Coulonval, I. Pirson, F. Lamy, J. E. Dumont, and P. P. Roger Thyrotropin via Cyclic AMP Induces Insulin Receptor Expression and Insulin Co-stimulation of Growth and Amplifies Insulin and Insulin-like Growth Factor Signaling Pathways in Dog Thyroid Epithelial Cells J. Biol. Chem., November 15, 1996; 271(46): 29400 - 29406. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Lazar, R. J. Wiese, M. J. Brady, C. C. Mastick, S. B. Waters, K. Yamauchi, J. E. Pessin, P. Cuatrecasas, and A. R. Saltiel Mitogen-activated Protein Kinase Kinase Inhibition Does Not Block the Stimulation of Glucose Utilization by Insulin J. Biol. Chem., September 1, 1995; 270(35): 20801 - 20807. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Wiese, C. C. Mastick, D. F. Lazar, and A. R. Saltiel Activation of Mitogen-activated Protein Kinase and Phosphatidylinositol 3`-Kinase Is Not Sufficient for the Hormonal Stimulation of Glucose Uptake, Lipogenesis, or Glycogen Synthesis in 3T3-L1 Adipocytes J. Biol. Chem., February 17, 1995; 270(7): 3442 - 3446. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. S. Rani, A. Abe, Y. Chang, N. Rosenzweig, A. R. Saltiel, N. S. Radin, and J. A. Shayman Cell Cycle Arrest Induced by an Inhibitor of Glucosylceramide Synthase J. Biol. Chem., February 10, 1995; 270(6): 2859 - 2867. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Miele, J. J. Rochford, N. Filippa, S. Giorgetti-Peraldi, and E. Van Obberghen Insulin and Insulin-like Growth Factor-I Induce Vascular Endothelial Growth Factor mRNA Expression via Different Signaling Pathways J. Biol. Chem., July 7, 2000; 275(28): 21695 - 21702. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |